UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021207
Receipt number R000024456
Scientific Title Studies in the effects of dietary intake of broccoli sprouts on intestinal microflora and bowel movements in healthy human subjects.
Date of disclosure of the study information 2016/03/01
Last modified on 2018/05/12 21:22:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Studies in the effects of dietary intake of broccoli sprouts on intestinal microflora and bowel movements in healthy human subjects.

Acronym

Effects of BS intake on human intestinal microflora

Scientific Title

Studies in the effects of dietary intake of broccoli sprouts on intestinal microflora and bowel movements in healthy human subjects.

Scientific Title:Acronym

Effects of BS intake on human intestinal microflora

Region

Japan


Condition

Condition

healthy human subjects with mild constipation

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine if dietary intake of sulforaphane-rich broccoli sprouts changes intestinal miroflora, and improves constipation in humans.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase I,II


Assessment

Primary outcomes

Intestinal microflora at 4 weeks after starting intake of broccoli sprouts(BS), and at 4 weeks after finishing intale of BS.

Key secondary outcomes

Constipation Assessment Scale
Bristol Stool Scale


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Pseudo-randomization


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Intervention Group (24 cases)
Broccoli Sprouts 20g/day for 4 weeks
(Sulforaphane Glucosinolate 88 mg/day)

Interventions/Control_2

Placebo Group (24 cases)
Alfalfa Sprouts 20g/day for 4 weeks
(Sulforaphane Glucosinolate 0 mg/day)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

healthy human subects without organic gastrointestinal diseases, and with mild constipation, whose constipation assessment score (CAS) is greater than 1.

Key exclusion criteria

Subjects
1) with organic gastrointestinal diseases
2) with allergy to broccoli or alfala
3) with taking any drugs, which affects intestinal microflora, and bowel movements
(e.g. NSAIDs, antibiotics,laxatives)

Target sample size

48


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yanaka, Akinori

Organization

Faculty of Medicine, University of Tsukuba

Division name

Hitachi Medical Education and Research Center

Zip code


Address

in Hitachi general hospital, 2-1-1 Jounan-cho, Hotachi-shi, Ibaraki-ken, 317-0077

TEL

0294-23-1111

Email

ynk-aki@md.tsukuba.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yanaka, Akinori

Organization

Faculty of Medicine, University of Tsukuba

Division name

Hitachi Medical education and Research Center

Zip code


Address

in Hitachi general hospital, 2-1-1 Jounan-cho, Hotachi-shi, Ibaraki-ken, 317-0077

TEL

0294-23-1111

Homepage URL


Email

ynk-aki@md.tsukuba.ac.jp


Sponsor or person

Institute

Univeristy of Tsukuba

Institute

Department

Personal name



Funding Source

Organization

Murakami Pharm, Inc

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 02 Month 01 Day

Date of IRB


Anticipated trial start date

2016 Year 03 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 02 Month 25 Day

Last modified on

2018 Year 05 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024456


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name